Home/ Supplements/ Omega 3/ Prenatal Omega-3

Prenatal Omega-3

product on market Softgel Capsule Melaleuca Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Fish oil concentrate provides omega-3 fatty acids, which are supported by strong evidence for fetal brain and visual development during pregnancy. These nutrients support cardiovascular health and cognitive function. The current evidence coverage for this specific profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Prenatal Omega-3
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Softgel(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Glycerin Lemon oil flavor Water
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Formulation Notes

Ideal for pregnant or nursing moms.

Formulated with pure coldwater omega-3 fish oils (1000 mg DHA, 400 mg EPA, and other essential fatty acid)

Additional Information

Supports prenatal brain development

Product Number: 8545

Promotes brain and eye development of prenatal babies

Give your baby a healthy head start with the recommended balance of DHA & EPA. Specifically formulated to support baby’s brain and eye development.

Metadata

Product Details

DSLD Entry Date2017-02-24
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID70937
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.